EyePoint Pharmaceuticals, Inc. financial data

Symbol
EYPT on Nasdaq
Industry
Laboratory Analytical Instruments
Location
480 Pleasant Street, Suite B300, Watertown, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
pSivida Corp. (to 3/30/2018), pSivida LTD (to 6/18/2008)
Latest financial report
10-K - Q4 2024 - Mar 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 568 % +57%
Quick Ratio 5.86 % -22.2%
Debt-to-equity 32.8 % -60.7%
Return On Equity -50.7 % +17.6%
Return On Assets -38.1 % -13.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68.7M shares +37.9%
Common Stock, Shares, Outstanding 68.3M shares +39.2%
Entity Public Float 451M USD +93.6%
Common Stock, Value, Issued 68K USD +38.8%
Weighted Average Number of Shares Outstanding, Basic 54.4M shares +42%
Weighted Average Number of Shares Outstanding, Diluted 54.4M shares +42%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 43.3M USD -5.97%
Research and Development Expense 133M USD +106%
Selling and Marketing Expense 131K USD -98.9%
General and Administrative Expense 52.4M USD +30.6%
Costs and Expenses 43.3M USD +46.2%
Operating Income (Loss) -146M USD -94.3%
Nonoperating Income (Expense) 15.1M USD +246%
Net Income (Loss) Attributable to Parent -131M USD -84.9%
Earnings Per Share, Basic -2.32 USD/shares -27.5%
Earnings Per Share, Diluted -2.32 USD/shares -27.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 99.7M USD -64.6%
Marketable Securities, Current 271M USD +445%
Cash, Cash Equivalents, and Short-term Investments 371M USD +12.1%
Inventory, Net 2.31M USD -41%
Other Assets, Current 1.41M USD +39.2%
Assets, Current 383M USD +11.2%
Property, Plant and Equipment, Net 8.18M USD +55.7%
Operating Lease, Right-of-Use Asset 21M USD +321%
Other Assets, Noncurrent 5.83M USD
Assets 418M USD +17.8%
Accounts Payable, Current 11.7M USD +80.2%
Employee-related Liabilities, Current 11.8M USD -6.34%
Accrued Liabilities, Current 18.1M USD +3.32%
Liabilities, Current 49M USD -22.5%
Operating Lease, Liability, Noncurrent 21.9M USD +346%
Other Liabilities, Noncurrent 205K USD
Liabilities 82M USD -7.76%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.03M USD +19%
Retained Earnings (Accumulated Deficit) -873M USD -17.6%
Stockholders' Equity Attributable to Parent 337M USD +26.4%
Liabilities and Equity 418M USD +17.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -31.2M USD -85.2%
Net Cash Provided by (Used in) Financing Activities 115K USD
Net Cash Provided by (Used in) Investing Activities 20.8M USD -35.2%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 68.3M shares +39.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.3M USD -201%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 99.9M USD -64.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 185M USD +26.6%
Deferred Tax Assets, Gross 191M USD +29.3%
Operating Lease, Liability 23.1M USD +322%
Depreciation 303K USD +189%
Payments to Acquire Property, Plant, and Equipment 1.19M USD +147%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -131M USD -84.8%
Lessee, Operating Lease, Liability, to be Paid 47.1M USD +649%
Property, Plant and Equipment, Gross 12.2M USD +56.4%
Operating Lease, Liability, Current 1.25M USD +121%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.13M USD +177%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.59M USD +309%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +103%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 24M USD +2825%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.22M USD +166%
Deferred Tax Assets, Operating Loss Carryforwards 103M USD +24.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.32M USD +103%
Operating Lease, Payments 274K USD +67.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 0 USD -100%
Share-based Payment Arrangement, Expense 36.7M USD +205%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%